- Home
- THTX vs YI Comparison
THTX vs YI Comparison
Compare THTX & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- YI
- Stock Information
- Founded
- THTX 1993
- YI 2010
- Country
- THTX Canada
- YI China
- Employees
- THTX N/A
- YI N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- YI Retail-Drug Stores and Proprietary Stores
- Sector
- THTX Health Care
- YI Consumer Staples
- Exchange
- THTX Nasdaq
- YI Nasdaq
- Market Cap
- THTX 71.3M
- YI 69.4M
- IPO Year
- THTX N/A
- YI N/A
- Fundamental
- Price
- THTX $1.50
- YI $9.05
- Analyst Decision
- THTX Hold
- YI
- Analyst Count
- THTX 1
- YI 0
- Target Price
- THTX N/A
- YI N/A
- AVG Volume (30 Days)
- THTX 2.9M
- YI 34.4K
- Earning Date
- THTX 04-09-2025
- YI 03-20-2025
- Dividend Yield
- THTX N/A
- YI N/A
- EPS Growth
- THTX N/A
- YI N/A
- EPS
- THTX N/A
- YI N/A
- Revenue
- THTX $85,866,000.00
- YI $1,973,017,082.00
- Revenue This Year
- THTX $3.57
- YI N/A
- Revenue Next Year
- THTX $7.73
- YI N/A
- P/E Ratio
- THTX N/A
- YI N/A
- Revenue Growth
- THTX 5.02
- YI N/A
- 52 Week Low
- THTX $1.08
- YI $0.41
- 52 Week High
- THTX $2.18
- YI $11.35
- Technical
- Relative Strength Index (RSI)
- THTX 44.19
- YI 52.67
- Support Level
- THTX $1.51
- YI $9.13
- Resistance Level
- THTX $2.12
- YI $10.52
- Average True Range (ATR)
- THTX 0.12
- YI 0.87
- MACD
- THTX 0.01
- YI -0.15
- Stochastic Oscillator
- THTX 7.46
- YI 43.46
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.